A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants

NCT05804162 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Cagrilintide
DRUG: Cagrilintide Placebo
DRUG: Moxifloxacin
DRUG: Moxifloxacin Placebo

Sponsor

Novo Nordisk A/S